LHRH conjugated gold nanoparticles assisted efficient ovarian cancer targeting evaluated via spectral photon-counting CT imaging: a proof-of-concept research

· 2023-03-01

Emerging multifunctional nanoparticulate formulations take advantage of nano-meter scale size and surface chemistry to work as a therapeutic delivery agent and a diagnostic tool for non-invasive real-time monitoring using SPCCT imaging technology.

Funding

Cancer Society of New Zealand

UO-15064

Cancer Society of New Zealand

UO-16589

Otago School of Medical Sciences

UO-13489

Cancer Research Trust New Zealand

GOT-1549-RPG